- Company Name
- Eliaz Therapeutics
- Company Description
- Eliaz Therapeutics is a pioneering medical technology company focused on developing a groundbreaking therapeutic apheresis
device for the treatment of Sepsis & Acute Kidney Injury (AKI). Eliaz Therapeutics has successfully completed feasibility and animal testing and is initiating a $20 million Series A for IDE-enabling development, clinical trials for Sepsis and Sepsis-AKI (S-AKI), and regulatory approval.
- Website
-
—
- Industry Type
-
Hematology
- Incoming Channel
- —